PAHC
Income statement / Annual
Last year (2025), Phibro Animal Health Corporation's total revenue was $1.30 B,
an increase of 27.37% from the previous year.
In 2025, Phibro Animal Health Corporation's net income was $48.26 M.
See Phibro Animal Health Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$1.30 B |
$1.02 B |
$977.89 M |
$942.26 M |
$833.35 M |
$800.35 M |
$828.00 M |
$820.00 M |
$764.30 M |
$751.50 M |
| Cost of Revenue |
$896.27 M
|
$704.59 M
|
$679.65 M
|
$656.86 M
|
$561.97 M
|
$543.47 M
|
$563.40 M
|
$553.10 M
|
$516.00 M
|
$512.50 M
|
| Gross Profit |
$399.94 M
|
$313.09 M
|
$298.24 M
|
$285.40 M
|
$271.38 M
|
$256.88 M
|
$264.60 M
|
$266.90 M
|
$248.30 M
|
$239.00 M
|
| Gross Profit Ratio |
0.31
|
0.31
|
0.3
|
0.3
|
0.33
|
0.32
|
0.32
|
0.33
|
0.32
|
0.32
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$12.08 M
|
$10.00 M
|
$9.44 M
|
$11.03 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$289.48 M
|
$259.78 M
|
$226.39 M
|
$206.41 M
|
$196.51 M
|
$187.69 M
|
$181.40 M
|
$168.00 M
|
$150.30 M
|
$153.30 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$289.48 M
|
$259.78 M
|
$226.39 M
|
$206.41 M
|
$196.51 M
|
$187.69 M
|
$181.40 M
|
$168.00 M
|
$150.30 M
|
$153.30 M
|
| Cost And Expenses |
$1.19 B
|
$964.36 M
|
$906.04 M
|
$863.28 M
|
$758.48 M
|
$731.16 M
|
$744.80 M
|
$721.10 M
|
$666.30 M
|
$665.80 M
|
| Interest Income |
$2.62 M
|
$4.47 M
|
$3.36 M
|
$816.00 K
|
$838.00 K
|
$1.76 M
|
$1.90 M
|
$1.69 M
|
$1.97 M
|
$256.00 K
|
| Interest Expense |
$33.25 M
|
$21.97 M
|
$17.95 M
|
$12.10 M
|
$10.40 M
|
$14.30 M
|
$13.68 M
|
$13.60 M
|
$16.87 M
|
$16.85 M
|
| Depreciation & Amortization |
$45.61 M
|
$36.18 M
|
$34.01 M
|
$32.71 M
|
$31.88 M
|
$32.34 M
|
$27.56 M
|
$26.94 M
|
$26.00 M
|
$23.45 M
|
| EBITDA |
$146.85 M |
$69.06 M |
$106.03 M |
$117.13 M |
$110.21 M |
$101.58 M |
$112.75 M |
$128.62 M |
$123.42 M |
$117.06 M |
| EBITDA Ratio |
0.11
|
0.07
|
0.11
|
0.12
|
0.13
|
0.13
|
0.14
|
0.16
|
0.16
|
0.16
|
| Operating Income Ratio |
0.09
|
0.05
|
0.07
|
0.08
|
0.09
|
0.09
|
0.09
|
0.12
|
0.13
|
0.11
|
| Total Other Income/Expenses Net |
-$42.47 M
|
-$42.40 M
|
-$17.78 M
|
-$6.66 M
|
-$8.40 M
|
-$13.68 M
|
-$11.72 M
|
-$10.86 M
|
-$17.39 M
|
-$19.44 M
|
| Income Before Tax |
$67.99 M
|
$10.92 M
|
$54.07 M
|
$72.33 M
|
$66.47 M
|
$55.51 M
|
$71.50 M
|
$88.10 M
|
$80.50 M
|
$76.80 M
|
| Income Before Tax Ratio |
0.05
|
0.01
|
0.06
|
0.08
|
0.08
|
0.07
|
0.09
|
0.11
|
0.11
|
0.1
|
| Income Tax Expense |
$19.73 M
|
$8.50 M
|
$21.47 M
|
$23.15 M
|
$12.08 M
|
$21.96 M
|
$16.80 M
|
$23.20 M
|
$15.90 M
|
-$6.00 M
|
| Net Income |
$48.26 M
|
$2.42 M
|
$32.61 M
|
$49.18 M
|
$54.39 M
|
$33.55 M
|
$54.70 M
|
$64.90 M
|
$64.60 M
|
$82.70 M
|
| Net Income Ratio |
0.04
|
0
|
0.03
|
0.05
|
0.07
|
0.04
|
0.07
|
0.08
|
0.08
|
0.11
|
| EPS |
1.19 |
0.06 |
0.81 |
1.21 |
1.34 |
0.83 |
1.35 |
1.61 |
1.63 |
2.11 |
| EPS Diluted |
1.19 |
0.06 |
0.81 |
1.21 |
1.34 |
0.83 |
1.35 |
1.61 |
1.61 |
2.07 |
| Weighted Average Shares Out |
$40.50 M
|
$40.50 M
|
$40.50 M
|
$40.50 M
|
$40.50 M
|
$40.50 M
|
$40.41 M
|
$40.20 M
|
$39.50 M
|
$39.30 M
|
| Weighted Average Shares Out Diluted |
$40.70 M
|
$40.52 M
|
$40.50 M
|
$40.50 M
|
$40.50 M
|
$40.50 M
|
$40.52 M
|
$40.40 M
|
$40.00 M
|
$40.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
